oppn parties Patanjali Corona Kit: False Claims To Cash-In On Health Fears

News Snippets

  • Calcutta HC said that an accused in a NDPS case is not entitled to default bail if a charge sheet, even without the chemical report, is filed within time
  • 21 killed in a hooch tragedy in Amritsar. Police arrested 10 persons
  • Incoming CJI Justice B R Gavai said that he will always strive for social and political justice
  • Although US Prez Donald trump once again claimed his administration brokered the ceasefire between India and Pakistan, India clearly refuted the claim and said it was workd out by the DGMO
  • Centre tells the Supreme Court that since women are not in combat roles, there has to be a separate selection board for them
  • India briefs 70 nations on Operation Sindoor
  • PM Modi asks Pakistan to vacate illegally-occupied portions of Kashmir
  • PM Modi tells Pakistan that it faces annihilation if it does not stop supporting terror
  • PM Modi visits Adampur IAF base, poses before the S-400 surface-to-air defence system to destrot Pakistan's claim that it had bombed the base and destroyed the defence system
  • 5 US companies make offers to GAIL for stake in LNG projects
  • Retail inflation dipped to 3.2% in April, the lowest since July 2019
  • Stocks tumble on Tuesday: After the all-time single-day gain on Monday, stocks lost heavily on Tuesday - Sensex went down by 1281 points to 81148 and Nifty lost 346 points to 24578
  • Indian tour to England: A new look Indian team with a new skipper will be announced when the selectors meet later this week in view of the retirement of Virat Kohli, Rohit Sharma and R Ashwin
  • IPL: Most overseas players to return and teams likely to be full strength
  • Sharad Pawar calls for an all-party meet to discuss Operation Sindoor, says such matter cannot be publicly discussed in Parliament as the Congress had earlier demanded
PM Modi warns Pakistan - stop supporting terror or face annihilation /////// Also asks Pakistan to vacate illegally-occupied portion of Kashmir
oppn parties
Patanjali Corona Kit: False Claims To Cash-In On Health Fears

By A Special Correspondent
First publised on 2020-06-25 13:42:45

Ramdev's Patanjali has released an ayurvedic formulation Coronil (being sold as a kit along with two other formulations, priced at Rs 545) which it claims is the first ayurvedic medicine for Covid-19. The government has asked it to stop making the erroneous claim. The Uttarakhand government has issued a clarification saying that Patanjali had applied for a license for making a medicine for boosting immunity, cough and fever which was granted to it. It also said that a notice has been issued to the company asking it to reply to why it was claiming that the drug cured Covid-19. States like Rajasthan and Maharashtra have already banned the sale of the formulation and more states are likely to do so.

It was unethical for Patanjali to make such a claim without proper trials and verification by drug bodies or the Ayush ministry of the government of India. By trying to cash in on the pandemic, Patanjali has shown that it is like other profit-minded pharma companies despite flaunting its credentials as a company rooted in making drugs as per ancient Hindu medicinal texts. It is beyond one's comprehension as to how ancient ayurveda texts could have anticipated the Covid-19 virus and prescribed a formulation to treat it. It should have promoted the drug for what it was - an immunity booster.

It is good that the Centre as well as the states have taken immediate steps to call its bluff and ask for an explanation. With citizens worried about their health due to the pandemic, such companies cannot be allowed to feed on this and fill their coffers by making false claims. Since people are trying a host of home remedies to boost immunity and since Patanjali has brand value, it is obvious that if the government does not step in to stop the sale of the dubious medicine there will be many takers for it. Patanjali should be asked to reposition the kit as one for boosting immunity and change its name before releasing it in the market.